Post Categories
Blog post not found!
A New Proteo-Genomic Map Shows How Genes Connect to a Variety of Diseases
February 7, 2022
Like the infamous Marauder’s Map in the Harry Potter novels, which revealed all the secrets of Hogwarts Castle, a recently published proteo-genomic map uncovers…
Sea Squirts and Missing Genes
February 2, 2022
It might seem odd to use a tiny sea creature to explore human genetics. However, as recently reported on Shamini Bundell’s Nature Podcast, marine…
Approved: First Drug to Boost Growth in Children With Dwarfism
January 31, 2022
The first drug to counter the genetic mutation that causes achondroplasia, the most common form of dwarfism, received accelerated FDA approval in November. BioMarin…
Collaborations Continue to Reveal the Potential of Understanding Protein Structure and Interactions
January 24, 2022
Proteins are a string of amino acids linked together in a specific sequence, with 20 possible amino acids coming into play. Each protein is…
A Novel Approach to a New mRNA-Based Lyme Disease Vaccine: Tick Saliva
January 17, 2022
Lyme disease is the most commonly reported tick-borne illness in the United States and the worldwide burden of Lyme disease has increased in recent…
Medicare: Rising Premiums and Novel AD Drugs
January 12, 2022
Medicare recently announced that its Part B outpatient premium will increase by $21.60 per month in 2022. The increase marks one of Medicare’s largest…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
QPS India has achieved another significant milestone by successfully completing a scheduled inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) from…
QPS Selects Ryght AI as an Exclusive AI Partner for Clinical Trial Optimization and Automation while adding to Ryght’s global site network. Laguna Beach,…
